Aberdeen Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,586,609
| Closed | -$12.9M | – | 963 |
|
|
2025
Q1 | $12.9M | Buy |
1,586,609
+205,834
| +15% | +$1.68M | 0.03% | 501 |
|
|
2024
Q4 | $13M | Sell |
1,380,775
-428,017
| -24% | -$4.03M | 0.02% | 459 |
|
|
2024
Q3 | $19.3M | Buy |
1,808,792
+150,179
| +9% | +$1.6M | 0.04% | 391 |
|
|
2024
Q2 | $16.5M | Buy |
1,658,613
+36,214
| +2% | +$359K | 0.03% | 421 |
|
|
2024
Q1 | $19.1M | Buy |
+1,622,399
| New | +$19.1M | 0.04% | 414 |
|